What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators
AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?
All-new webinar featuring Jane Pine Wood and Richard Cooper to share expertise with clinical lab and pathology groups on actions to take now in preparation for 2017’s tougher lab regulations and new legal issues
AUSTIN, Texas (October 5, 2016) Tougher challenges are coming to all labs in 2017, with the new year bringing significant changes to lab test reimbursement, lab compliance, and managed care contracting. Most of these challenges all boil down to one thing: tougher actions by government and private payers which are expected to have negative financial consequences for the nation’s medical laboratories and pathology groups.
Clock is ticking down on the nation’s medical laboratories, as they struggle to comply with the PAMA Final Rule and reporting of Lab Test Market Price Data to Medicare, beginning in just 100 days
AUSTIN, Texas (September 20, 2016) Reporting of Lab Test Market Price Data to Medicare officials starts in about 100 days and the news is not good. Across the nation, clinical laboratories and their experts admit that they are struggling to comply with the final PAMA rule. And this is just the larger labs.
Most Pathologists Unware of New Federal MACRA Law Accelerating Medicare’s Transition Away from Fee-for-Service Payment: Upcoming Webinar to Prepare Pathologists for MIPS and New Medicare Payment Models
AUSTIN, Texas (August 22, 2016) Consulting company Deloitte says that most doctors are unaware of a new federal law poised to make major changes in how physicians—including pathologists—are paid for Medicare physician professional services. The first sections of MACRA become effective on January 1, 2017. That leaves just 120 days for pathologists and their practice administrators to learn about the law, develop strategies to comply, and prepare to be paid differently by the Medicare Program.
Research demonstrating the clinical utility and associated health economics benefits of PgX grows, resulting in tremendous new opportunities for clinical laboratories and pathology groups
AUSTIN, Texas (August 1, 2016) – Increased understanding of the genetic basis of an individual’s response to drugs, including how and how quickly a drug is metabolized (pharmacodynamics and pharmacokinetics), has opened the door to a more personalized approach to drug prescription. By identifying drugs most likely to benefit a patient, assessing the likely dose response, potentially avoiding adverse reactions, and reducing unnecessary use of drugs, pharmacogenomics testing (PgX) is helping to optimize treatment and reduce costs associated with complications or inappropriate utilization.
New webinar to share real-world success strategies with clinical laboratories and pathology groups on how to get paid for lab tests in today’s tough managed care marketplace
AUSTIN, Texas (May 19, 2016) — Getting paid for lab tests is becoming increasingly tougher for nearly every clinical laboratory and pathology group in the United States. Not only are payers getting tougher on how they reimburse labs, but ever more frequently labs must collect significant dollars directly from patients who have large copays or deductibles.
PRESS RELEASE: New webinar taps the expertise of Henry Ford Health lab team to educate and inform clinical laboratories and pathology groups on how to boost the value of their lab testing services
AUSTIN, Texas (April 8, 2016) — Nearly all clinical labs and pathology groups now feel the double squeeze of shrinking budgets and less reimbursement from health insurers. As a result, innovative laboratories are taking steps to cut costs while at the same time developing lab testing services that deliver more value to physicians, patients, and payers.
PRESS RELEASE: Clinical Laboratory Industry’s First-Ever Learning Track for Lab Mentors and their Mentorees Is Part of the 21st Annual Executive War College on Lab and Pathology Management
AUSTIN, Texas (March 21, 2016) — Every lab needs a succession planning program that mentors its up-and-coming leaders, and that is exactly what will be offered at the 21st annual Executive War College on Laboratory and Pathology Management, April 26-27, 2016 in New Orleans.
PRESS RELEASE: Clinical Laboratory Industry’s First-Ever ‘National Lab Sales Excellence Award’ Is Part of the 21st Annual Executive War College on Lab and Pathology Management
AUSTIN, Texas (March 21, 2016) — It’s an historic first for the clinical laboratory industry! The nation’s top producing laboratory sales professionals will be recognized for their achievements when the winners of the first-ever National Lab Sales Excellence Award are announced at this year’s 21st annual Executive War College on Laboratory and Pathology Management, on April 26-27, 2016 in New Orleans.
New Webinar to Detail Practical Strategies for Clinical Labs Regarding Appropriate Test Selection, Enhanced Error Reduction, and Improved Patient Outcomes When Ordering Expensive Send-out Molecular and Genetic Tests (Webinar)
AUSTIN, Texas (March 11, 2016) — Clinical laboratories are introducing 10 new molecular and genetic tests every day, a rate of growth that has produced 60,000 tests currently available for clinical use. This remarkable number means finding and ordering the right test is more challenging for labs than ever before.
Molecular Information Management Systems (MIMS) revolutionize personalized and predictive medicine for pathology laboratories
AUSTIN, Texas (February 8, 2016) – As molecular technology and personalized medicine increasingly becomes the default position for clinical diagnostics laboratories, these modalities place significant demands on laboratory information systems. Although hospitals and healthcare institutions often focus on an electronic medical records system that includes a laboratory information system (LIS), those LIS’s do not typically have the functionality needed to handle current molecular testing needs, or needs expected in the near future.
New webinar to educate and inform clinical laboratories and pathology groups on how to combine real-time analytics with medical laboratory information systems to improve lab operations, cut costs, and boost productivity (Webinar)
AUSTIN, Texas (February 5, 2016) — Clinical diagnostic laboratories are an indispensable component of modern healthcare. Yet labs, which often operate as separate business units or even as separate businesses, are facing increased competition from within the industry as well as a push for increased efficiency with lower levels of reimbursement. Without having reliable, concrete business metrics at their fingertips, laboratory managers are finding it increasingly difficult to make the most effective operational decisions and efficiently troubleshoot problems.
Two respected clinical laboratories initiate simple process improvements resulting in improved inventory management, hundreds of thousands of dollars in wasted spending captured, and increased lab performance
AUSTIN, Texas (December 29, 2015) — Two of the nation’s most respected laboratory organizations recently saw the opportunity to convert inventory to cash, using existing staff and resources to initiate simple and speedy process improvements. The result was money the labs could spend immediately, while at the same time reducing expensive inventory levels, and eliminating stock-outs and the problem of expired reagents
Nation’s clinical laboratories and pathology groups to rely once again on Lab Quality Confab for solutions, as pressure continues to cut laboratory costs and deliver enhanced clinical value
AUSTIN, Texas (September 25, 2015) — The topic of cost-cutting at clinical laboratories and anatomic pathology groups across the nation remains key. It is budget season, meaning hospitals and labs are being told to aggressively reduce their costs in 2016. Health insurers continue to pay less for medical lab testing. These two factors make the management challenge for labs clear: Get better at cutting costs and moving those resources to lab activities that add clinical value to physicians and payers, and improve patient outcomes.
Tougher demands like reimbursement challenges, and the need to reduce lab costs while improving patient care force clinical laboratories to reclassify expansion of automated lab functions from ‘optional’ to ‘must-do’
AUSTIN, Texas (June 15, 2015) – Today’s clinical laboratories are under the constant challenge to produce ever-faster turnaround times, while reducing errors. And as pressure intensifies to cut healthcare costs, laboratories are relying increasingly on automation not only to achieve these goals, but also to improve patient care and maintain lab profitability.
New Webinar set to help laboratories respond effectively to 2015’s new and tougher payer requirements for lab claims
AUSTIN, Texas (May 15, 2015) — With the arrival of 2015, payers began processing lab test claims differently. The import of this development is that every lab that is serious about filing clean claims and getting faster payment has realized that a clear understanding of the coding, billing, and collection changes that have descended upon the lab industry is crucial.
New webinar to help laboratories meet most recent accrediting standards and achieve the goal of being inspection-ready at all times
AUSTIN, Texas (April 10, 2015) — Laboratories must now comply with increasing regulatory requirements. This expansion of existing requirements places a heavier burden on every lab striving to maintain regulatory readiness every day—not just when the bi-annual inspection is due.
Challenges lie ahead for Meaningful Use and the federal government’s electronic health record (EHR) incentive program: Webinar to address recent developments and how laboratories can execute better interfaces for their client physicians
AUSTIN, Texas (March 12, 2015) — Of the 1,956 ambulatory “complete” EHRs certified in 2011, only 547 were certified at the end of 2014. That means 75% of certified EHR systems have failed to gain certification as compliant with the requirements of Meaningful Use Stage 2. Most lab managers are surprised to learn that nearly 1,500 EHR systems are likely to never become certified as compliant with MU-2. As a consequence, many of these labs’ client physicians will be stuck with an EHR product that does not certify as MU-2 compliant, and thus likely to be assessed a penalty of at least a 1% cut in their Medicare reimbursement, as early as this year.
Government and private health insurers increase audits, compliance checks, and claims challenges: Webinar to address key preparations clinical labs and pathology groups should make for next round of payer audits
AUSTIN, Texas (February 12, 2015) — Clinical laboratories and pathology groups are reporting greater scrutiny of lab test claims and more audit activity by payers. Increased attention is going into new areas of lab billing and collections, such as out-of-network billing. Another area of heightened investigation by private health insurers and Medicare program officials is that of medical necessity.
Clinical laboratories have until January 1, 2016 to meet Medicare’s New IQCP Requirements: Important new webinar to cover essential steps laboratories must take immediately, and what lab staffs must do to prepare
AUSTIN, Texas (January 9, 2015) — Compliance with CLIA requirements is essential for every medical laboratory that performs non-waived testing. A major change in how labs must meet quality control standards is about to take place, with an effective date of January 1, 2016. This new development opens up a way for laboratories to meet the quality control standards of CLIA. The revisions published by CMS now allow labs to develop and use an IQCP (Individual Quality Control Plan) as a way to meet these new quality control standards.